Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01942850 · ClinicalTrials.gov registry record
International Ataxia Rating Scale in Younger Patients
A clinical trial, sponsored by Quince Therapeutics S.p.A..
- Completed
- Registry status
- 63
- Enrollment target
NCT01942850: Completed study, sponsored by Quince Therapeutics S.p.A..
NCT01942850 is a clinical trial that has completed, run by Quince Therapeutics S.p.A.. The registered enrollment target is 63 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01942850 has completed, sponsored by Quince Therapeutics S.p.A..
- COMPLETED
- Registry status
- 63 participants
- Enrollment target
Study Summary
The project will collect information on the mapping of clinical ratings on a number of scales that are used in the assessment of patients with ataxias.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2013-08 |
| Est. Completion | 2014-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01942850
The ClinicalTrials.gov registry entry for NCT01942850 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Quince Therapeutics S.p.A., which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01942850 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01942850 about?
NCT01942850 is a clinical study titled "International Ataxia Rating Scale in Younger Patients". The project will collect information on the mapping of clinical ratings on a number of scales that are used in the assessment of patients with ataxias.
What is the current status of trial NCT01942850?
This trial is currently completed. The enrollment target is 63 participants. The study started on 2013-08. Estimated completion is 2014-05.
Who is sponsoring clinical trial NCT01942850?
This trial is sponsored by Quince Therapeutics S.p.A., which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.